AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	4	5	57	48	23
Market Cap Growth	-39.07%	-5.61%	-91.95%	19.21%	111.31%	-47.37%
Enterprise Value	10	10	10	63	54	28
PE Ratio	-	-0.54	-0.77	-3.45	-7.10	-3.34
PS Ratio	47.81	109.47	516.45	942.06	-	28.28
PB Ratio	-0.40	-0.57	-0.95	-24.36	30.51	-3.34
P/FCF Ratio	-1.53	-4.20	-2.23	-22.45	-14.42	-4.50
P/OCF Ratio	-1.54	-4.20	-2.24	-22.90	-14.86	-4.50
EV/Sales Ratio	121.32	248.70	1149.40	1045.70	-	35.28
EV/EBITDA Ratio	-4.60	-4.23	-2.41	-10.77	-11.13	-4.34
EV/EBIT Ratio	-3.80	-3.57	-2.19	-7.92	-11.10	-4.34
EV/FCF Ratio	-4.74	-9.54	-4.97	-24.92	-16.19	-5.62
Debt / Equity Ratio	-0.84	-0.72	-1.17	-2.87	4.03	-0.90
Debt / EBITDA Ratio	-3.16	-2.43	-1.34	-1.14	-1.31	-0.94
Debt / FCF Ratio	-3.25	-5.49	-2.76	-2.65	-1.90	-1.22
Quick Ratio	0.02	0.03	0.01	0.18	0.31	0.32
Current Ratio	0.02	0.03	0.03	0.25	0.48	0.48
Asset Turnover	0.02	0.01	0.00	0.01	0	0.47
Interest Coverage	-1.81	-2.28	-2.48	-16.44	-15.43	-20.08
Return on Equity (ROE)	75.24%	105.60%	123.45%	706.45%	-429.85%	100.16%
Return on Assets (ROA)	-141.35%	-194.40%	-141.43%	-310.29%	-59.49%	-400.23%
Return on Capital (ROIC)	230.98%	139.37%	-554.34%	-182.27%	-62.84%	990.80%
Earnings Yield	-136.98%	-186.30%	-129.97%	-29.00%	-14.09%	-29.95%
FCF Yield	-48.00%	-23.82%	-44.79%	-4.45%	-6.93%	-22.20%
Buyback Yield / Dilution	-21.87%	-37.60%	-25.79%	-19.16%	-78.19%	-8.14%
Total Shareholder Return	-21.87%	-37.60%	-25.79%	-19.16%	-78.19%	-8.14%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.